EAS Sound Processor Acoustic-Only Post-Implant Mode

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Hearing loss patients with residual low-frequency hearing and severe high-frequency loss cannot benefit from traditional hearing aids or cochlear implants during the post-implant waiting period after surgical implantation of electro-acoustic stimulation systems, and it is difficult for clinicians to assess their residual hearing during this time.

Innovation Solution

An electro-acoustic stimulation (EAS) sound processor is configured to operate in an acoustic-only mode immediately after implantation, providing acoustic stimulation while preventing electrical stimulation, allowing patients to benefit from residual hearing enhancement and facilitating assessment of hearing changes during the healing period, and switching to an EAS mode after healing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If the EAS system is activated immediately after implantation, then the patient can benefit from both acoustic and electrical stimulation, but the patient's residual hearing cannot be properly assessed during the healing period

Engineering Contradiction:
Improvehearing benefit durationVSAvoidresidual hearing assessment accuracy
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The system divides operation into distinct modes: acoustic-only mode for the post-implant assessment period, and full EAS mode for normal operation. This segmentation allows the assessment function to be isolated and performed without interference from electrical stimulation, while still providing hearing benefit during the healing period.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system dynamically switches between different operational states based on the implantation timeline. The sound processor transitions from acoustic-only operation during the post-implant period to full EAS operation after healing, allowing optimal performance for each phase of recovery and use.

Inventive Principle:
Principle #15Dynamics

2Measurement precision

If the patient waits for the post-implant healing period before using the EAS system, then residual hearing can be assessed, but the patient loses the benefit of hearing enhancement during the waiting period

Engineering Contradiction:
Improveresidual hearing assessment accuracyVSAvoidhearing benefit delay
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The system performs preliminary acoustic fitting and assessment during the post-implant period before full EAS activation. This preliminary action establishes baseline measurements and allows the patient to benefit from acoustic amplification of residual hearing while healing, without waiting for the complete system activation.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The sound processor is designed to perform multiple functions: it provides acoustic amplification during the post-implant assessment period, enables residual hearing measurement, and later transitions to full EAS operation. This multi-functionality eliminates the need to choose between assessment and hearing benefit.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Productivity

If electrical stimulation is applied during the post-implant period, then the patient receives high frequency stimulation, but it may interfere with the assessment of residual low frequency hearing

Engineering Contradiction:
Improvehearing stimulation effectivenessVSAvoidresidual hearing measurement accuracy
Core Design Contradiction:
ProductivityVSLoss of information

Solution Approach 1:

The system extracts the electrical stimulation component during the post-implant period, operating in acoustic-only mode. This removal of electrical stimulation eliminates interference with residual hearing assessment while maintaining the ability to provide acoustic amplification for low frequency residual hearing.

Inventive Principle:
Principle #2Taking out (Extraction)

Data Source

PatentEP3110501B1Systems for facilitating post-implant acoustic-only operation of an electro-acoustic stimulation ("EAS") sound processor
Publication Date: 2019.06.19 ADVANCED BIONICS AG
  • EP3110501B1 patent drawingFigure 1
  • EP3110501B1 patent drawingFigure 2
  • EP3110501B1 patent drawingFigure 3

AI summary

An exemplary system includes 1) an electro-acoustic stimulation ("EAS") sound processor located external to a patient, 2) a cochlear implant communicatively coupled to the EAS sound processor and implanted within the patient, 3) an electrode array communicatively coupled to the cochlear implant and located within a cochlea of the patient, and 4) a receiver communicatively coupled to the EAS sound processor and configured to be in communication with an ear of the patient. The EAS sound processor operates in accordance with an acoustic-only mode during a post-implant time period and detects audio content presented to the patient, directs the receiver to apply acoustic stimulation, and prevents the cochlear implant from applying electrical stimulation representative of audio content presented to the patient during the post-implant time period. Corresponding systems and methods are also disclosed.